The significance of acid/base properties in drug discovery

被引:235
作者
Manallack, David T. [1 ]
Prankerd, Richard J. [1 ]
Yuriev, Elizabeth [1 ]
Oprea, Tudor I. [2 ]
Chalmers, David K. [1 ]
机构
[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
[2] Univ New Mexico, Sch Med, Dept Internal Med, Translat Informat Div, Albuquerque, NM 87131 USA
关键词
BRAIN-BARRIER PERMEATION; P-GLYCOPROTEIN; HERG LIABILITY; IN-VIVO; PHOSPHOLIPIDOSIS; PREDICTION; BINDING; ABSORPTION; RULES; SET;
D O I
10.1039/c2cs35348b
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
While drug discovery scientists take heed of various guidelines concerning drug-like character, the influence of acid/base properties often remains under-scrutinised. Ionisation constants (pK(a) values) are fundamental to the variability of the biopharmaceutical characteristics of drugs and to underlying parameters such as logD and solubility. pK(a) values affect physicochemical properties such as aqueous solubility, which in turn influences drug formulation approaches. More importantly, absorption, distribution, metabolism, excretion and toxicity (ADMET) are profoundly affected by the charge state of compounds under varying pH conditions. Consideration of pK(a) values in conjunction with other molecular properties is of great significance and has the potential to be used to further improve the efficiency of drug discovery. Given the recent low annual output of new drugs from pharmaceutical companies, this review will provide a timely reminder of an important molecular property that influences clinical success.
引用
收藏
页码:485 / 496
页数:12
相关论文
共 62 条
[1]   FUNCTIONAL-GROUP CONTRIBUTIONS TO DRUG RECEPTOR INTERACTIONS [J].
ANDREWS, PR ;
CRAIK, DJ ;
MARTIN, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (12) :1648-1657
[2]  
Avdeef A., 2003, ABSORPTION DRUG DEV
[3]   The Drug Transporter-Metabolism Alliance: Uncovering and Defining the Interplay [J].
Benet, Leslie Z. .
MOLECULAR PHARMACEUTICS, 2009, 6 (06) :1631-1643
[4]   A Medicinal Chemist's Guide to Molecular Interactions [J].
Bissantz, Caterina ;
Kuhn, Bernd ;
Stahl, Martin .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (14) :5061-5084
[5]   Development of Specific "Drug-Like Property" Rules for Carboxylate-Containing Oral Drug Candidates [J].
Boecker, Alexander ;
Bonneau, Pierre R. ;
Hucke, Oliver ;
Jakalian, Araz ;
Edwards, Paul J. .
CHEMMEDCHEM, 2010, 5 (12) :2102-2113
[6]   Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: Importance of drug ionisation in the in vitro prediction of in vivo absorption [J].
Boisset, M ;
Botham, RP ;
Haegele, KD ;
Lenfant, B ;
Pachot, JI .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 10 (03) :215-224
[7]   Improving the prediction of the brain disposition for orally administered drugs using BDDCS [J].
Broccatelli, Fabio ;
Larregieu, Caroline A. ;
Cruciani, Gabriele ;
Oprea, Tudor I. ;
Benet, Leslie Z. .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (01) :95-109
[8]   A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields [J].
Broccatelli, Fabio ;
Carosati, Emanuele ;
Neri, Annalisa ;
Frosini, Maria ;
Goracci, Laura ;
Oprea, Tudor I. ;
Cruciani, Gabriele .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) :1740-1751
[9]   Enhancement of oral absorption in selective 5-HT1D receptor agonists:: Fluorinated 3-[3-(piperidin-1-yl)propyl]indoles [J].
Castro, JL ;
Collins, I ;
Russell, MGN ;
Watt, AP ;
Sohal, B ;
Rathbone, D ;
Beer, MS ;
Stanton, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) :2667-2670
[10]   In silico prediction of blood-brain barrier permeation [J].
Clark, DE .
DRUG DISCOVERY TODAY, 2003, 8 (20) :927-933